- Home
- DCTH
DCTH
Delcath Systems Inc.
as 11-15-2024 4:00pm EST
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | QUEENSBURY |
| Market Cap: | 305.2M | IPO Year: | N/A |
| Target Price: | $21.50 | AVG Volume (30 days): | 445.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.38 - $12.88 | Next Earning Date: | 11-08-2024 |
| Revenue: | $22,644,000 | Revenue Growth: | 945.91% |
| Revenue Growth (this year): | 1562.76% | Revenue Growth (next year): | 117.72% |
Latest Delcath Systems Inc. News
DCTH Breaking Stock News: Dive into DCTH Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
Delcath Systems Third Quarter 2024 Earnings: Beats Expectations
GuruFocus.com
8 days ago
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Business Wire
9 days ago
Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
Business Wire
16 days ago
Delcath Systems to Participate in Upcoming Investor Conferences
Business Wire
23 days ago
Delcath Systems to Host Third Quarter 2024 Earnings Call
Business Wire
a month ago
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
Business Wire
2 months ago
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
2 months ago
Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
Compare DCTH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DCTH Delcath Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.